Inhalation & Respiratory Drug Delivery 2018
29th - 30th October 2018, New York, USA
This year’s event is designed for senior industry experts that will showcase new trends in aerosol science and the future directions of inhalation drug delivery research.
Further discussion focuses on the regulatory pathways for inhaled therapies and challenges of bringing respiratory products to market. The agenda also features key case studies on the latest trends in inhalation devices, from inhaled insulin to gene therapy.
Over 200+ delegates representing global pharmaceutical organisations, leading biotech companies and internationally renowned academic institutions will be joining the Inhalation & Respiratory Drug Delivery 2018
The global pulmonary drug delivery market is projected to reach USD 52.37 Billion by 2021 from USD 36.10 Billion in 2016, at a CAGR of 6.5% during the forecast period. Growth in this market is mainly driven by increasing preference of pulmonary route of drug delivery, increasing technological developments in the form of smart/digital inhalers and rising incidences of respiratory diseases such as COPD, asthma, and cystic fibrosis.
Over 20+ presentations and case studies focused on the key issues in inhalation and respiratory drug delivery. Join us at the Inhalation & Respiratory Drug Delivery 2018 in New York
The BioTech Pharma Summit: Inhalation & Respiratory Drug Delivery 2018 will focus on the challenges of bringing respiratory products to market and innovative aerosol science, including modelling and toxicology. Presentations will also feature key case studies on the latest trends in inhalation devices, from inhaled insulin to gene therapy to overcome lung and pulmonary conditions, such as COPD, asthma and cystic fibrosis.